
Clinical Trial Endpoints in Oncology
OncoPharm
00:00
When to Use Overall Survival
John Bazar discusses assessing curable versus metastatic disease and when median or landmark overall survival is appropriate.
Play episode from 02:31
Transcript

John Bazar discusses assessing curable versus metastatic disease and when median or landmark overall survival is appropriate.